According to a new report, published by KBV research, The Global Interventional Pulmonology Market size is expected to reach $5.9 billion by 2029, rising at a market growth of 6.9% CAGR during the forecast period.
The Bronchoscopes segment acquired maximum revenue share in the Global Interventional Pulmonology Market by Product in 2022 thereby, achieving a market value of $2 billion by 2029. They are using cutting-edge nonreactive materials like silicon coating. To stop the growth of microbial films, bronchoscopes are coated with antimicrobial materials. In addition, Higher-resolution cameras are incorporated into the creation of bronchoscopes as part of the manufacturer's product development strategy, resulting in an incredibly thin manufacturing process.
The COPD segment has shown the growth rate of 7.7% during (2023 - 2029). The term "chronic obstructive pulmonary disease" (COPD) is used to refer generally to the progressive, long-term state of lung diseases such as chronic bronchitis and asthma. The market will expand due to an increase in the demand for interventional pulmonary procedures due to an increase in COPD cases. Compared to fresher smokers, the rates of COPD are even higher among existing and former smokers.
The Hospitals segment is leading the Global Interventional Pulmonology Market by End-user in 2022 thereby, achieving a market value of $2.7 billion by 2029. This is brought on by several developments, including the growth of the healthcare infrastructure, a rise in health expenditure, the aging of the population, and the existence of a sizable patient population. The market for interventional pulmonology is growing quickly due to technological developments and a rise in the availability of specialist services in hospitals.
The North America market dominated the Global Interventional Pulmonology Market by Region in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2.3 billion by 2029. The Europe market is exhibiting a CAGR of 6.5% during (2023 - 2029). Additionally, The Asia Pacific market would display a CAGR of 7.9% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/interventional-pulmonology-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Boston Scientific Corporation, Becton, Dickinson and Company, Olympus Corporation, Fujifilm Holdings Corporation, ICU Medical, Inc. (Smiths Medical), HUGER Medical Instrument Co., Ltd, Cook Medical, Inc. (Cook Group), Clarus Medical LLC and Vygon SAS.
By Product
By Indication
By End-user
By Geography
Companies Profiled
Unique Offerings 
